T. Hylan

发表

Antidepressant Selection and Use and Healthcare Expenditures

W. Crown, T. Hylan, L. Meneades, 1998, PharmacoEconomics.

Initial Treatment Choice in Depression

S. Coons, J. Draugalis, E. Edgell, 2000, PharmacoEconomics.

Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.

W. Crown, T. Croghan, J. Heiligenstein, 1998, Journal of affective disorders.

Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines

R. Dunn, R. Ozminkowski, J. Donoghue, 1999, Journal of psychopharmacology.

Predictors of a medical-offset effect among patients receiving antidepressant therapy.

G. Oster, W. McMullen, D. Buesching, 1998, The American journal of psychiatry.

SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.

W. Crown, T. Croghan, J. Heiligenstein, 1999, Medical care.

SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.

W. Crown, A. Montejo, J. Sacristán, 1999 .

Recovery from depression, work productivity, and health care costs among primary care patients.

W. Katon, D. Revicki, G. Simon, 2000, General hospital psychiatry.

Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system.

W. Crown, R. Ozminkowski, T. Croghan, 1998, Clinical therapeutics.

Using natural language processing to identify problem usage of prescription opioids

David Cronkite, David S. Carrell, Roy E. Palmer, 2015, Int. J. Medical Informatics.

Antidepressant use in clinical practice: efficacy v. effectiveness

J. Donoghue, T. Hylan, 2001, British Journal of Psychiatry.

The Coase Theorem, Free Agency, and Major League Baseball: A Panel Study of Pitcher Mobility from 1961 to 1992*

M. Lage, M. Treglia, T. Hylan, 1996 .

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.

R. Judge, K. Sundell, T. Hylan, 1999, Journal of women's health & gender-based medicine.

Costs of Depressive Disorders: A Review

J. Rosenbaum, T. Hylan, 2001 .

Antidepressant Use and Clinical and Economic Outcomes in a Primary Care Psychiatry Center in Spain

W. Crown, A. Montejo, J. Sacristán, 1999 .

Automated prediction of risk for problem opioid use in a primary care setting.

Kathleen Saunders, David Cronkite, David Carrell, 2015, The journal of pain : official journal of the American Pain Society.

A framework for drug utilization evaluation in depression: insights from outcomes research.

K. Summers, J. Bootman, E. Edgell, 1999, Medical care.

Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in The Netherlands: a multivariate analysis.

L. Sverdlov, A. Pathiyal, T. Hylan, 1997, Clinical therapeutics.

SSRI antidepressant selection and concomitant prescribing of anxiolytics and sedative-hypnotics: evidence from primary care in the United Kingdom

M. Treglia, T. Hylan, C. Neslusan, 1998 .

The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes

Kathleen Saunders, David Cronkite, Roy E. Palmer, 2015, Pain.

Using natural language processing to identify problem usage of prescription opioids

Roy E. Palmer, David E. Gross, D. Carrell, 2015, Int. J. Medical Informatics.

Health economic evaluations of antidepressants: A review

G. Tollefson, D. Buesching, T. Hylan, 1998, Depression and anxiety.

Antidepressant use and resource utilization in the general practitioner setting in The Netherlands

A. Pathiyal, T. Hylan, Judith K Jones, 1998, Pharmacoepidemiology and Drug Safety.

A review of methodologies for assessing drug effectiveness and a new proposal: randomized database studies.

J. Sacristán, T. Hylan, I. Galende, 1997, Clinical therapeutics.